Skip to main content
Fig. 7 | Journal of Neuroinflammation

Fig. 7

From: Increased regulatory activity of intestinal innate lymphoid cells type 3 (ILC3) prevents experimental autoimmune encephalomyelitis severity

Fig. 7

Effects of Ffar2 agonist Cpd1 on EAE. DA rats were immunized with SCH and treated orally with Cpd1 (15 mg/kg, q.d., n = 12) or vehicle (water, n = 14) 0–5 d.p.i. Clinical scores were monitored daily and presented as mean ± SEM (A). Clinical parameters of EAE observed in a single experiment are presented as mean ± SD (B–F). Distribution of rats among clinical groups was determined on day 28 d.p.i. (G). *p < 0.05, ns—not significant

Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094